Welcome to NewPressRelease.com a free press release service. Publishing press releases for Public Relations never been easier. Just register (it's free and it takes less then a 1 minute) then use Submit Press Release. Our services aim to help you reach journalists and to improve visibility in search engine listings, so you can get the most publicity possible.

Global Autoimmune Monoclonal Antibodies Market by Source, Application, and End User Industry Report

Health and Fitness

(Free Press Release) Autoimmune Monoclonal Antibodies Market By Source (Murine, Chimeric, Humanized, & Human), By Application (Systemic Lupus Erythematosus, Rheumatoid Arthritis, Multiple Sclerosis, Transplant Rejection/Graft Versus Host Disease, & Others), and By End User (Hospitals/Clinics, Research Institutes, & Diagnostic Laboratories)

Global Autoimmune Monoclonal Antibodies Market by Source, Application, and End User Industry Report


Global Autoimmune Monoclonal Antibodies market is expected to reach USD 25,274.7 million by 2021 from USD 17,329.5 million in 2016, growing at a CAGR of 7.84% during forecast period 2016-2021. Irregular functioning of humans’ immune system results in autoimmune disorders. Overproduction of self-reactive immune cells (such as antibodies & T-cells) damage regular functions of /cells/tissues/organs. This lead to different autoimmune disorders such as systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, and others diseases. Typically, drugs are used as a treatment to cure autoimmune disorders. The adverse effects associated with drugs has made switched to concentrate on monoclonal antibodies.

Browse full report @ https://www.marketdataforecast.com/market-reports/global-autoimmune-monoclonal-antibodies-1170/

Monoclonal antibodies have the ability to offer less toxic and more efficient therapeutic alternatives to treat autoimmune diseases. Recent years have seen the emergence of monoclonal antibodies being used to treat wide array of diseases that are related to immune response. These antibodies are mono-specific comprising of identical immune cells which are clones of a single parent cell and are directed towards a specific cellular target. Thus monoclonal antibodies due to its customizable nature can be used to treat the self-reactive immune cells not impacting the normal ones.

Request sample report @ https://www.marketdataforecast.com/market-reports/global-autoimmune-monoclonal-antibodies-1170/request-sample

Growing research & development to stimulate the development of monoclonal antibodies rising number of patients with autoimmune diseases, and increasing public & private organizations involvement to support advanced therapeutics development are driving the growth of global autoimmune monoclonal antibodies market. In addition, rising demand for antibody based therapeutics, increasing adoption of advanced healthcare therapeutics, and growing number of lifestyle associated disorders are further promoting the growth of global autoimmune monoclonal antibodies. However, presence of stringent regulatory pathways, lack of advanced research facilities & underdeveloped healthcare infrastructure in certain developing regions, and limited accessibility of monoclonal antibodies therapeutics due to high cost are restraining the growth of autoimmune monoclonal antibodies.

Inquire before buying report @ https://www.marketdataforecast.com/market-reports/global-autoimmune-monoclonal-antibodies-1170/inquire

Market Segmentation

§ By Source                   

· Murine

· Chimeric 

· Humanized

· Human

§ By Application


§ Systemic Lupus Erythematosus


§ Rheumatoid Arthritis


§ Multiple Sclerosis


§ Transplant Rejection/Graft Versus Host Disease


§ Others


o End User


§ Hospitals/Clinics


§ Research Institute


§ Diagnostic Laboratories


On the basis of geographical region the global Autoimmune Monoclonal Antibodies market is segmented as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America is expected to command the major market share of 45.0% of the global Autoimmune Monoclonal Antibodies market in 2016 and expected to grow at the highest CAGR of 8.47% during the forecast period 2016-2021.

Request discount report @ https://www.marketdataforecast.com/market-reports/global-autoimmune-monoclonal-antibodies-1170/request-discount

The key players in global Autoimmune Monoclonal Antibodies market include, GlaxoSmithKline plc (U.K.), AstraZeneca plc (U.K.), F. Hoffmann-La Roche Ltd. (Switzerland), Bristol-Myers Squibb (U.S.), Johnson & Johnson (U.S.), Innovent Biologics, Inc. (China), Takeda Pharmaceutical Company Ltd. (Japan), Amgen Inc. (U.S.), Biogen Inc.(U.S.), and UCB Company (Belgium).

Buy full report @ https://www.marketdataforecast.com/cart/buy-now/global-autoimmune-monoclonal-antibodies-1170/

About Market Data Forecast:

Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com


Abhishek Shukla

Sales Manager (International Business Development)

Market Data Forecast

Direct Line: +1-888-702-9626

Mobile: +91 998 555 0206

Mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/

View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases



Global Autoimmune Monoclonal Antibodies Market by Source, Application, and End User Industry Report

Source: Press Release



If you have any questions regarding information in this press release, please contact the person listed as the Author or use the contact informations published in the press release. Please do not attempt to contact NewPressRelease.com. We are unable to assist you with any information regarding this release. NewPressRelease.com disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.

All press release information on this site, including free press releases, is solely based on what our users submit. NewPressRelease.com disclaims that any right and responsibility for the information goes to the user who submit the press release. Some press release may be confusing without additional explanation. You should contact the provider with any questions about the information presented. In case some press release damages your benefits or violate your rights in any way, please contact us and we'll remove it immediately.

Copyright © 2008 - 2018 Free Press Release by NewPressRelease.com